These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8970715)

  • 1. HIV viral dynamics.
    Coffin JM
    AIDS; 1996 Dec; 10 Suppl 3():S75-84. PubMed ID: 8970715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV viral load quantification, HIV resistance, and antiretroviral therapy.
    Katzenstein DA; Holodniy M
    AIDS Clin Rev; 1995-1996; ():277-303. PubMed ID: 7488557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model of HIV infection: Simulating T4, T8, macrophages, antibody, and virus via specific anti-HIV response in the presence of adaptation and tropism.
    Wasserstein-Robbins F
    Bull Math Biol; 2010 Jul; 72(5):1208-53. PubMed ID: 20151219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of HIV persistence: implications for vaccines and therapy.
    Bremermann HJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):459-83. PubMed ID: 7627623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS pathogenesis: from models to viral dynamics in patients.
    Nowak MA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S1-5. PubMed ID: 8595501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.
    Coffin JM
    Science; 1995 Jan; 267(5197):483-9. PubMed ID: 7824947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral strategies in the replication of human immunodeficiency virus].
    Wainberg MA; Bour S; Geleziunas R; Bentwich Z
    Union Med Can; 1992; 121(5):307-9, 312-4. PubMed ID: 1279875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do we need to do to cure HIV infection.
    Siliciano RF
    Top HIV Med; 2010; 18(3):104-8. PubMed ID: 20921575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication timetable setback.
    TreatmentUpdate; 1999 May; 11(3):3-4. PubMed ID: 11366780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
    Zhang L; Ramratnam B; Tenner-Racz K; He Y; Vesanen M; Lewin S; Talal A; Racz P; Perelson AS; Korber BT; Markowitz M; Ho DD
    N Engl J Med; 1999 May; 340(21):1605-13. PubMed ID: 10341272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 dynamics in vivo: implications for therapy.
    Simon V; Ho DD
    Nat Rev Microbiol; 2003 Dec; 1(3):181-90. PubMed ID: 15035022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral dynamics in human immunodeficiency virus type 1 infection.
    Wei X; Ghosh SK; Taylor ME; Johnson VA; Emini EA; Deutsch P; Lifson JD; Bonhoeffer S; Nowak MA; Hahn BH
    Nature; 1995 Jan; 373(6510):117-22. PubMed ID: 7529365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.
    Trono D; Van Lint C; Rouzioux C; Verdin E; Barré-Sinoussi F; Chun TW; Chomont N
    Science; 2010 Jul; 329(5988):174-80. PubMed ID: 20616270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV infection: future perspective for a so-called fatal disease?].
    von Overbeck J; Iten A
    Schweiz Med Wochenschr; 1997 Mar; 127(13):521-7. PubMed ID: 9190663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minority memory genomes can influence the evolution of HIV-1 quasispecies in vivo.
    Briones C; de Vicente A; Molina-París C; Domingo E
    Gene; 2006 Dec; 384():129-38. PubMed ID: 17059869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.